Opko Health held its 2024 Annual Meeting of Stockholders, where all eleven nominees were elected to the Board of Directors, an amendment to increase the authorized number of shares was approved, the compensation of executive officers was approved on a non-binding basis, and the appointment of Ernst & Young LLP as the independent registered public accounting firm was ratified.